Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral cephalosporins.

J Verhaegen1, L Verbist

  • 1Department of Bacteriology, U.Z. St Rafaël, Leuven, Belgium.

Acta Clinica Belgica
|January 1, 1992
PubMed
Summary

Choosing the right cephalosporin is confusing. Newer agents like cefaclor and cefuroxime axetil show better in vitro activity but have lower serum concentrations than older cephalosporins, with amoxicillin-clavulanate offering a comparable alternative.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Operative management of isolated posterior cruciate ligament injuries improves stability and reduces the incidence of secondary osteoarthritis: a systematic review.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2021
Same author

How small modifications in laboratory workflow of blood cultures can have a significant impact on time to results.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2018
Same author

Added diagnostic value and impact on antimicrobial therapy of 16S rRNA PCR and amplicon sequencing on resected heart valves in infective endocarditis: a prospective cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Performance of three generations of Xpert MRSA in routine practice: approaching the aim?

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Same author

Characterisation of Staphylococcus aureus isolates from bloodstream infections, Democratic Republic of the Congo.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Same author

Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • The increasing number of cephalosporin antibiotics presents a challenge for clinicians in selecting the optimal drug.
  • Older cephalosporins (cephalexin, cephradine, cefadroxil) and newer formulations (cefaclor, cefatrizine, cefuroxime axetil) are widely used for mild to moderate infections.

Purpose of the Study:

  • To compare the pharmacokinetic profiles and in vitro activity of older and newer cephalosporins.
  • To evaluate amoxicillin-clavulanate as a potential alternative to newer cephalosporins.

Main Methods:

  • Comparative analysis of pharmacokinetic profiles (serum concentrations) and in vitro activity against key pathogens.
  • Evaluation of efficacy and cost-effectiveness of amoxicillin-clavulanate versus cefaclor and cefuroxime axetil.

Main Results:

  • Older cephalosporins possess better pharmacokinetic profiles but exhibit reduced activity against Gram-positive and Gram-negative bacteria compared to newer agents.
  • Cefaclor, cefatrizine, and cefuroxime axetil demonstrate enhanced in vitro activity against specific pathogens like H. influenzae, S. aureus, and M. catarrhalis.
  • Despite improved in vitro activity, newer cephalosporins achieve lower mean free serum concentrations than older agents at standard doses. Amoxicillin-clavulanate shows comparable efficacy, superior pharmacokinetics, and lower cost than cefaclor and cefuroxime axetil.

Conclusions:

  • Clinicians must weigh the improved in vitro activity of newer cephalosporins against their less favorable pharmacokinetic profiles.
  • Amoxicillin-clavulanate emerges as a cost-effective and pharmacokinetically reliable alternative for treating mild to moderate infections, comparable in efficacy to certain newer cephalosporins.

Related Experiment Videos